Literature DB >> 20564248

Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease.

Carolina A M Kulak1, Victoria C Borba, Vanda Jorgetti, Luciene M Dos Reis, Xiaowei S Liu, Donald B Kimmel, Jaime Kulak, Leda M Rabelo, Hua Zhou, X Edward Guo, John P Bilezikian, Cesar L Boguszewski, David W Dempster.   

Abstract

Chronic obstructive pulmonary disease (COPD) is associated with osteoporosis and fragility fractures. The objectives of this study were to assess static and dynamic indices of cancellous and cortical bone structure in postmenopausal women with COPD. Twenty women with COPD who had not received chronic oral glucocorticoids underwent bone biopsies after double tetracycline labeling. Biopsies were analyzed by histomorphometry and µCT and compared with age-matched controls. Distribution of the patients according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) was: Type I (15%), Type II (40%), Type III (30%), and Type IV (15%). Mean (±SD) cancellous bone volume (15.20 ± 5.91 versus 21.34 ± 5.53%, p = .01), trabecular number (1.31 ± 0.26 versus 1.77 ± 0.51/mm, p = .003), and trabecular thickness (141 ± 23 versus 174 ± 36 µm, p = .006) were lower in patients than in controls. Connectivity density was lower in COPD (5.56 ± 2.78 versus 7.94 ± 3.08/mm, p = .04), and correlated negatively with smoking (r = -0.67; p = .0005). Trabecular separation (785 ± 183 versus 614 ± 36 µm, p = .01) and cortical porosity (4.11 ± 1.02 versus 2.32 ± 0.94 voids/mm(2); p < .0001) were higher in COPD while cortical width (458 ± 214 versus 762 ± 240 µm; p < .0001) was lower. Dynamic parameters showed significantly lower mineral apposition rate in COPD (0.56 ± 0.16 versus 0.66 ± 0.12 µm/day; p = .01). Patients with more severe disease, GOLD III and IV, presented lower bone formation rate than GOLD I and II (0.028 ± 0.009 versus 0.016+ 0.011 µm(3)/µm(2)/day; p = 04). This is the first evaluation of bone microstructure and remodeling in COPD. The skeletal abnormalities seen in cancellous and cortical bone provide an explanation for the high prevalence of vertebral fractures in this disease.
© 2010 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564248     DOI: 10.1002/jbmr.88

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  19 in total

Review 1.  Osteoporosis after transplantation.

Authors:  Carolina A Moreira Kulak; Victoria Z Cochenski Borba; Jaime Kulak; Melani Ribeiro Custódio
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

Review 2.  Skeletal Implications of Chronic Obstructive Pulmonary Disease.

Authors:  Barbara M Misof; Carolina A Moreira; Klaus Klaushofer; Paul Roschger
Journal:  Curr Osteoporos Rep       Date:  2016-04       Impact factor: 5.096

3.  Abnormal microarchitecture and stiffness in postmenopausal women using chronic inhaled glucocorticoids.

Authors:  Y Liu; E Dimango; M Bucovsky; S Agarwal; K Nishiyama; X E Guo; E Shane; E M Stein
Journal:  Osteoporos Int       Date:  2018-06-11       Impact factor: 4.507

4.  Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.

Authors:  R Watanabe; N Tai; J Hirano; Y Ban; D Inoue; R Okazaki
Journal:  Osteoporos Int       Date:  2017-11-22       Impact factor: 4.507

5.  COPD as an independent risk factor for osteoporosis and fractures.

Authors:  M G Adas-Okuma; S S Maeda; M R Gazzotti; C M Roco; C O Pradella; O A Nascimento; E F Porto; J G H Vieira; J R Jardim; M Lazaretti-Castro
Journal:  Osteoporos Int       Date:  2019-12-06       Impact factor: 4.507

Review 6.  The Skeletal Effects of Inhaled Glucocorticoids.

Authors:  Stephanie A Sutter; Emily M Stein
Journal:  Curr Osteoporos Rep       Date:  2016-06       Impact factor: 5.096

7.  Recommendations for Diagnosis and Management of Osteoporosis in COPD Men.

Authors:  Elias E Mazokopakis; Ioannis K Starakis
Journal:  ISRN Rheumatol       Date:  2011-08-10

8.  'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammation.

Authors:  Federica Bozzano; Francesco Marras; Maria Libera Ascierto; Claudia Cantoni; Giovanni Cenderello; Chiara Dentone; Antonio Di Biagio; Giancarlo Orofino; Eugenio Mantia; Silvia Boni; Pasqualina De Leo; Antonino Picciotto; Fulvio Braido; Francesca Antonini; Ena Wang; Francesco Marincola; Lorenzo Moretta; Andrea De Maria
Journal:  Nat Commun       Date:  2015-10-05       Impact factor: 14.919

Review 9.  Osteoporosis in chronic obstructive pulmonary disease.

Authors:  Malay Sarkar; Rajeev Bhardwaj; Irappa Madabhavi; Jasmin Khatana
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-03-12

10.  [Osteoporosis in pneumological diseases : Joint guideline of the Austrian Society for Bone and Mineral Research (ÖGKM) and the Austrian Society for Pneumology (ÖGP)].

Authors:  Christian Muschitz; Ralf Harun Zwick; Judith Haschka; Hans Peter Dimai; Martina Rauner; Karin Amrein; Robert Wakolbinger; Peter Jaksch; Ernst Eber; Peter Pietschmann
Journal:  Wien Klin Wochenschr       Date:  2021-06-16       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.